• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭与肾功能变化:重在理解,而非反应。

Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting.

机构信息

Department of Medicine, Section of Cardiology, University of Chicago Medicine, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

Department of Medicine, Am. Heart Assoc. Comprehensive Hypertension Center, University of Chicago Medicine, 5841 South Maryland Avenue, MC1027, Chicago, IL 60637, USA.

出版信息

Heart Fail Clin. 2019 Oct;15(4):455-461. doi: 10.1016/j.hfc.2019.06.006. Epub 2019 Jul 20.

DOI:10.1016/j.hfc.2019.06.006
PMID:31472881
Abstract

The kidney is a regulatory organ and accommodates changes in cardiac function. There is cross-talk between the kidney and the heart. In heart failure, the kidney acts as a bystander but also contributes to several maladaptive processes. The pathophysiology of worsening kidney function and its association with prognosis are discussed, as are other aspects of how worsening kidney function contributes to increased cardiovascular risk. Data suggest that morbidity and mortality reduction in people with heart failure and kidney disease requires use of a renin angiotensin system blocker, beta blocker, and mineralocorticoid receptor antagonist, as well as an SGLT 2 inhibitor.

摘要

肾脏是一个调节器官,可以适应心脏功能的变化。肾脏和心脏之间存在相互作用。在心力衰竭中,肾脏既是旁观者,也是多种适应性不良过程的参与者。本文讨论了肾功能恶化的病理生理学及其与预后的关系,以及肾功能恶化如何增加心血管风险的其他方面。数据表明,心力衰竭和肾脏病患者的发病率和死亡率降低需要使用肾素-血管紧张素系统阻滞剂、β受体阻滞剂和盐皮质激素受体拮抗剂,以及 SGLT2 抑制剂。

相似文献

1
Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting.心力衰竭与肾功能变化:重在理解,而非反应。
Heart Fail Clin. 2019 Oct;15(4):455-461. doi: 10.1016/j.hfc.2019.06.006. Epub 2019 Jul 20.
2
Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.心力衰竭治疗后肾功能的变化:聚焦于肾素-血管紧张素系统阻断
Heart Fail Clin. 2008 Oct;4(4):425-38. doi: 10.1016/j.hfc.2008.03.007.
3
Recent changes in the landscape of combination RAS blockade.联合RAS阻断领域的近期变化。
Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127.
4
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.醛固酮受体拮抗剂与伴有左心室功能障碍的心房颤动患者的心血管死亡率:来自心房颤动和充血性心力衰竭试验的观察。
Circ Heart Fail. 2012 Sep 1;5(5):586-93. doi: 10.1161/CIRCHEARTFAILURE.111.965160. Epub 2012 Jul 12.
5
[Are all antihypertensive drugs renoprotective?].[所有抗高血压药物都具有肾脏保护作用吗?]
Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6.
6
Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.肾素-血管紧张素系统阻断在心血管疾病治疗中的优势。
Med Arh. 2010;64(5):295-9.
7
Hypertension in Patients with Heart Failure with Reduced Ejection Fraction.射血分数降低的心力衰竭患者的高血压
Curr Cardiol Rep. 2016 Dec;18(12):127. doi: 10.1007/s11886-016-0807-9.
8
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).血管紧张素转换酶抑制剂治疗期间心力衰竭患者肾功能下降的预测因素:左心室功能障碍研究(SOLVD)的结果
Am Heart J. 1999 Nov;138(5 Pt 1):849-55. doi: 10.1016/s0002-8703(99)70009-8.
9
Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.出院后1年内肾功能恶化是急性失代偿性心力衰竭全因死亡率的一个强有力的独立预测因素。
J Am Heart Assoc. 2014 Nov 4;3(6):e001174. doi: 10.1161/JAHA.114.001174.
10
The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure.选择性醛固酮受体拮抗剂用于治疗高血压和充血性心力衰竭的前景。
Curr Hypertens Rep. 2000 Aug;2(4):378-83. doi: 10.1007/s11906-000-0041-z.

引用本文的文献

1
Growth Differentiation Factor 15 is Correlated With Urinary Markers in Patients with Chronic Heart Failure.生长分化因子15与慢性心力衰竭患者的尿液标志物相关。
Arq Bras Cardiol. 2025 Mar;122(3):e20240153. doi: 10.36660/abc.20240153.
2
The association between blood urea nitrogen to serum albumin ratio and 28 day in-hospital mortality in patients with chronic heart failure and sepsis: a pilot retrospective study.慢性心力衰竭合并脓毒症患者血尿素氮与血清白蛋白比值与28天院内死亡率的关联:一项初步回顾性研究
Front Cardiovasc Med. 2025 Mar 4;12:1491331. doi: 10.3389/fcvm.2025.1491331. eCollection 2025.
3
Machine Learning-Based Mortality Prediction in Chronic Kidney Disease among Heart Failure Patients: Insights and Outcomes from the Jordanian Heart Failure Registry.
基于机器学习的心力衰竭合并慢性肾脏病患者死亡率预测:来自约旦心力衰竭注册研究的结果和启示
Medicina (Kaunas). 2024 May 19;60(5):831. doi: 10.3390/medicina60050831.
4
The Impact of a New Arterial Intravascular Pump on Aorta Hemodynamic Surrounding: A Numerical Study.新型动脉血管内泵对主动脉周围血流动力学的影响:一项数值研究。
Bioengineering (Basel). 2022 Oct 13;9(10):547. doi: 10.3390/bioengineering9100547.
5
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial.利拉鲁肽对射血分数降低的心力衰竭患者肾功能恶化的影响:FIGHT 试验的结果。
Circ Heart Fail. 2020 May;13(5):e006758. doi: 10.1161/CIRCHEARTFAILURE.119.006758. Epub 2020 May 4.
6
Paradoxical Cardiorenal Responses Following Acute Vasodilator/Natriuretic Treatment in Presystolic Heart Failure: Should We Be Surprised?收缩前期心力衰竭患者急性血管扩张剂/利钠剂治疗后的矛盾性心肾反应:我们应该感到惊讶吗?
JACC Basic Transl Sci. 2019 Dec 23;4(8):973-975. doi: 10.1016/j.jacbts.2019.11.002. eCollection 2019 Dec.